Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism

BACKGROUND: Intracranial hemorrhage (ICH) is a common and often devastating outcome in patients with brain tumors. Despite this, there is little evidence to guide anticoagulation management following an initial ICH event. OBJECTIVES: To analyze the risk of recurrent hemorrhagic and thrombotic outcom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Res Pract Thromb Haemost
Main Authors: Carney, Brian J., Uhlmann, Erik J., Puligandla, Maneka, Mantia, Charlene, Weber, Griffin M., Neuberg, Donna S., Zwicker, Jeffrey I.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles: Thrombosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7354400/
https://ncbi.nlm.nih.gov/pubmed/32685895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12377
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados